|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
Human embryonic stem (hES) cells are usually established
and maintained on mouse embryonic fibroblasts (MEFs)
feeder layers. However, it is desirable to develop human
feeder cells because animal feeder cells are associated
with risks such as viral infection and/or pathogen
transmission. In this study, we attempted to establish new
hES cell lines using human uterine endometrial cells
(hUECs) to prevent the risks associated with animal feeder
cells and for their eventual application in cell
replacement therapy. Inner cell masses (ICMs) of cultured
blastocysts were isolated by immunosurgery and then
cultured on mitotically inactivated hUEC feeder layers.
Cultured ICMs formed colonies by continuous proliferation
and were allowed to proliferate continuously for 40, 50,
and 55 passages. The established hES cell lines
(Miz-hES14, -15, and -9, respectively) exhibited typical
hES cells characteristics including continuous growth,
expression of specific markers, normal karyotypes, and
differentiation capacity. hUEC feeders have the advantage
that they can be used for many passages, whereas MEF
feeder cells can only be used as feeder cells for a
limited number of passages. hUECs are available to
establish and maintain hES cells, and the high expression
of embryotrophic factors and extracellular matrices by
hUECs may be important to the efficient growth of hES
cells. Clinical applications require the establishment and
expansion of hES cells under stable xeno-free culture systems.
Key words:
Embryo
This article has been cited by other articles:
![]() |
C. Unger, H. Skottman, P. Blomberg, M. Sirac Dilber, and O. Hovatta Good manufacturing practice and clinical-grade human embryonic stem cell lines Hum. Mol. Genet., April 15, 2008; 17(R1): R48 - R53. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mannello and G. A. Tonti Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder-Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum-Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold! Stem Cells, July 1, 2007; 25(7): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mantel, Y. Guo, M. R. Lee, M.-K. Kim, M.-K. Han, H. Shibayama, S. Fukuda, M. C. Yoder, L. M. Pelus, K.-S. Kim, et al. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability Blood, May 15, 2007; 109(10): 4518 - 4527. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Allegrucci and L.E. Young Differences between human embryonic stem cell lines Hum. Reprod. Update, March 1, 2007; 13(2): 103 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Skottman and O. Hovatta Culture conditions for human embryonic stem cells. Reproduction, November 1, 2006; 132(5): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Trounson The Production and Directed Differentiation of Human Embryonic Stem Cells Endocr. Rev., April 1, 2006; 27(2): 208 - 219. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |